Using US Twinkling Artifact to Identify Breast Biopsy Markers: Brief Report.
Christine U LeeMara A PiltinDan MoldoveanuMatthew W UrbanGina K HesleyPublished in: Radiology. Imaging cancer (2023)
Breast biopsy markers play an essential role in the surgical management of patients with clinically node-positive breast cancer. Marking a pathology-proven lymph node ensures accurate imaging assessment of response to neoadjuvant systemic therapy and decreased false-negative rates in sentinel lymph node biopsy. There is a clinically unmet need to make breast biopsy markers, particularly in the axilla, more sonographically visible or identifiable for preoperative localization purposes. Previously described color Doppler US twinkling artifact of some breast biopsy markers in in vitro gel phantoms and in ex vivo cadaveric breasts suggests that twinkling of such markers can be leveraged for improved in vivo detection. In this retrospective case series of eight female patients (mean age, 58.6 years ± 12.3 [SD]), conventional B-mode US imaging failed to identify the biopsy marker associated with a surgical target in the breast or in an axillary lymph node. However, in each patient, the marker was successfully identified with the help of color Doppler US twinkling. Keywords: Breast, Ultrasound, Color Doppler US, Lymphatic, Artifacts, Biopsy Marker Published under a CC BY 4.0 license.
Keyphrases
- lymph node
- ultrasound guided
- sentinel lymph node
- fine needle aspiration
- neoadjuvant chemotherapy
- high resolution
- positive breast cancer
- magnetic resonance imaging
- rectal cancer
- end stage renal disease
- stem cells
- ejection fraction
- cross sectional
- newly diagnosed
- radiation therapy
- magnetic resonance
- chronic kidney disease
- computed tomography
- randomized controlled trial
- hyaluronic acid
- patients undergoing
- mass spectrometry
- fluorescence imaging
- label free
- patient reported
- loop mediated isothermal amplification